Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Clark

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2009
Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New YorkDon Weiss, Eric J Stern, Christopher Zimmerman, et al.
Clinical and Vaccine Immunology : CVI|January 14, 2011
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccinePaul A Kristiansen, Fabien Diomandé, Stanley C Wei, et al.
Journal of the American Medical Directors Association|February 7, 2021
Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing HomeFarrell A Tobolowsky, Ana C Bardossy, Dustin W Currie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2012
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunityPaul A Kristiansen, Fabien Diomandé, Absatou Ky Ba, et al.
Pediatrics|April 29, 2015
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University OutbreakLucy A McNamara, Alice M Shumate, Peter Johnsen, et al.
The New England Journal of Medicine|February 28, 2009
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North AmericaHenry M Wu, Brian H Harcourt, Cynthia P Hatcher, et al.
The Lancet. Infectious Diseases|October 20, 2018
Outbreak of Neisseria meningitidis serogroup C outside the meningitis belt-Liberia, 2017: an epidemiological and laboratory investigationCatherine H Bozio, Jeni Vuong, E Kainne Dokubo, et al.
JAMA|April 30, 2021
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021Isaac See, John R Su, Allison Lale, et al.
The Journal of Infectious Diseases|November 1, 2019
MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of AfricaJaymin C Patel, Heidi M Soeters, Alpha Oumar Diallo, et al.
Vaccine|May 22, 2012
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experienceMamoudou H Djingarey, Rodrigue Barry, Mete Bonkoungou, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2009
Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New YorkDon Weiss, Eric J Stern, Christopher Zimmerman, et al.
Clinical and Vaccine Immunology : CVI|January 14, 2011
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccinePaul A Kristiansen, Fabien Diomandé, Stanley C Wei, et al.
Journal of the American Medical Directors Association|February 7, 2021
Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing HomeFarrell A Tobolowsky, Ana C Bardossy, Dustin W Currie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2012
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunityPaul A Kristiansen, Fabien Diomandé, Absatou Ky Ba, et al.
Pediatrics|April 29, 2015
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University OutbreakLucy A McNamara, Alice M Shumate, Peter Johnsen, et al.
The New England Journal of Medicine|February 28, 2009
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North AmericaHenry M Wu, Brian H Harcourt, Cynthia P Hatcher, et al.
The Lancet. Infectious Diseases|October 20, 2018
Outbreak of Neisseria meningitidis serogroup C outside the meningitis belt-Liberia, 2017: an epidemiological and laboratory investigationCatherine H Bozio, Jeni Vuong, E Kainne Dokubo, et al.
JAMA|April 30, 2021
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021Isaac See, John R Su, Allison Lale, et al.
The Journal of Infectious Diseases|November 1, 2019
MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of AfricaJaymin C Patel, Heidi M Soeters, Alpha Oumar Diallo, et al.
Vaccine|May 22, 2012
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experienceMamoudou H Djingarey, Rodrigue Barry, Mete Bonkoungou, et al.
Pageof 9